Have a personal or library account? Click to login
Methodological Issues in Clinical Drug Development for Essential Tremor Cover

Methodological Issues in Clinical Drug Development for Essential Tremor

Tremor and Other Hyperkinetic Movements
Volume 2 (2012): Issue 0
By: Michael A. Carranza,  Madeline R. Snyder,  Rodger J. Elble,  Angelique E. Boutzoukas and  Theresa A. Zesiewicz  
Open Access
|Aug 2012

Authors

Michael A. Carranza

info@ubiquitypress.com

Department of Neurology, University of South Florida, Tampa, Florida

Madeline R. Snyder

info@ubiquitypress.com

Department of Neurology, University of South Florida, Tampa, Florida

Rodger J. Elble

info@ubiquitypress.com

Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois

Angelique E. Boutzoukas

info@ubiquitypress.com

Department of Neurology, University of South Florida, Tampa, Florida

Theresa A. Zesiewicz

tzesiewi@health.usf.edu

Department of Neurology, University of South Florida, Tampa, Florida
DOI: https://doi.org/10.5334/tohm.116 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Oct 13, 2011
Accepted on: May 30, 2012
Published on: Aug 6, 2012
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Essential tremor,
methodology,
tremor,
etiology

© 2012 Michael A. Carranza, Madeline R. Snyder, Rodger J. Elble, Angelique E. Boutzoukas, Theresa A. Zesiewicz, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 2 (2012): Issue 0Next article